• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Xenetic Biosciences released FY2025 9 Months earnings on November 12, 2025 (EST), with actual revenue of USD 2.21 M and EPS of USD -1.3629
04:00
Xenetic Biosciences released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 1.027 M (forecast USD 643.58 K), actual EPS USD -0.3306 (forecast USD -0.49)
04:00
Aug13
Xenetic Biosciences released FY2025 Semi-Annual earnings on August 12 (EST), actual revenue USD 1.183 M (forecast USD 1.362 M), actual EPS USD -1.0322 (forecast USD -1.51)
03:00
Xenetic Biosciences released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 589.9 K (forecast USD 660.67 K), actual EPS USD -0.45 (forecast USD -0.64)
03:00
Jul8
Xenetic Biosciences Launches Clinical Study on DNase I and FOLFIRINOX for Pancreatic Cancer
13:00
May14
Xenetic Biosciences Reports Q1 2025 Earnings
12:06

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.027 M, Net Income -509.94 K, EPS -0.3306

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 589.9 K, Net Income -688.7 K, EPS -0.4465

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 593.26 K, Net Income -903.14 K, EPS -0.5856

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
PCLA
0.3600
+192.45%
+0.237
STEC
1.530
+59.38%
+0.570
HIHO
1.250
+50.60%
+0.420
TRIB
1.280
+43.50%
+0.388
EUDA
1.920
+41.18%
+0.560
AFJK
44.010
+37.49%
+12.000
SOC
10.360
+36.32%
+2.760
POM
0.3499
+30.95%
+0.083
ASTI
5.060
+30.41%
+1.180
ASPC
16.100
+29.42%
+3.660
View More